Credit Suisse Downgrades Teva Pharma (TEVA) to Underperform
Tweet Send to a Friend
(Updated - August 24, 2017 6:22 AM EDT)Credit Suisse downgraded Teva Pharma (NYSE: TEVA) from Neutral to Underperform, price target ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
